{"id":"https://openalex.org/W4392722326","doi":"https://doi.org/10.1158/1940-6207.c.6546872","title":"Data from Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model","display_name":"Data from Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4392722326","doi":"https://doi.org/10.1158/1940-6207.c.6546872"},"language":"en","primary_location":{"id":"doi:10.1158/1940-6207.c.6546872","doi":"https://doi.org/10.1158/1940-6207.c.6546872","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6546872","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1940-6207.c.6546872","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010224493","display_name":"Swati Chandra","orcid":"https://orcid.org/0000-0002-0136-4231","observed_orcids":["https://orcid.org/0000-0002-0136-4231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Swati Chandra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090592078","display_name":"Ariel C. Nymeyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ariel C. Nymeyer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058439331","display_name":"Photini F. S. Rice","orcid":"https://orcid.org/0000-0001-7100-4023","observed_orcids":["https://orcid.org/0000-0001-7100-4023"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Photini Faith Rice","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108364106","display_name":"Eugene W. Gerner","orcid":"https://orcid.org/0000-0002-9906-8501","observed_orcids":["https://orcid.org/0000-0002-9906-8501"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugene W. Gerner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021337936","display_name":"Jennifer K. Barton","orcid":"https://orcid.org/0000-0003-4897-9361","observed_orcids":["https://orcid.org/0000-0003-4897-9361"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer K. Barton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10552","display_name":"Colorectal Cancer Screening and Detection","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulindac","display_name":"sulindac","score":0.9990000128746033},{"id":"https://openalex.org/keywords/colorectal-cancer-chemoprevention","display_name":"colorectal cancer chemoprevention","score":0.9779999852180481},{"id":"https://openalex.org/keywords/intermittent-dosing","display_name":"intermittent dosing","score":0.9670000076293945},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.859000027179718},{"id":"https://openalex.org/keywords/tumor-burden","display_name":"tumor burden","score":0.6740000247955322},{"id":"https://openalex.org/keywords/tumor-latency","display_name":"tumor latency","score":0.800000011920929},{"id":"https://openalex.org/keywords/optical-coherence-tomography","display_name":"optical coherence tomography","score":0.7549999952316284},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2778452354","wikidata":"https://www.wikidata.org/wiki/Q794084","display_name":"Azoxymethane","level":4,"score":0.9949914813041687},{"id":"https://openalex.org/C2776241388","wikidata":"https://www.wikidata.org/wiki/Q963093","display_name":"Sulindac","level":3,"score":0.9325519800186157},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7214926481246948},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5528638958930969},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.517892599105835},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44211941957473755},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4144176244735718},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2531954050064087},{"id":"https://openalex.org/C2778484676","wikidata":"https://www.wikidata.org/wiki/Q20707196","display_name":"Nonsteroidal","level":2,"score":0.08948644995689392}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1940-6207.c.6546872","doi":"https://doi.org/10.1158/1940-6207.c.6546872","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6546872","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1940-6207.c.6546872","doi":"https://doi.org/10.1158/1940-6207.c.6546872","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1940-6207.c.6546872","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2625961828","https://openalex.org/W4362617129","https://openalex.org/W4362617165","https://openalex.org/W2101721166","https://openalex.org/W1584314654","https://openalex.org/W2157052021","https://openalex.org/W2331310418","https://openalex.org/W2122953993","https://openalex.org/W2354527937","https://openalex.org/W1520185676"],"abstract_inverted_index":{"Abstract":[0],"Sulindac":[1],"is":[2,222],"an":[3,197],"NSAID":[4],"that":[5],"can":[6,203],"provide":[7,182,204],"effective":[8,206],"chemoprevention":[9,25,207],"for":[10,23,66,71,77,86,93],"colorectal":[11,34,209],"cancer.":[12,35],"In":[13],"this":[14,169,212],"study,":[15],"alternative":[16],"dosing":[17],"regimens":[18],"of":[19,33,118,130,168,180,189,208,216,225],"sulindac":[20,76,92,101,181,190,217],"were":[21,62],"evaluated":[22],"their":[24],"effectiveness":[26],"in":[27,51,116,156,191,211],"the":[28,52,56,131,157,165,183],"azoxymethane-treated":[29],"A/J":[30],"mouse":[31],"model":[32],"High-resolution":[36],"endoscopic":[37],"optical":[38],"coherence":[39],"tomography":[40],"was":[41,151],"utilized":[42],"to":[43],"time-serially":[44],"measure":[45],"tumor":[46,49,111,139],"number":[47,117],"and":[48,98,104,113,141,171],"burden":[50],"distal":[53],"colon":[54],"as":[55],"biological":[57],"endpoints.":[58],"Four":[59],"treatment":[60,132,170,218],"groups":[61,133],"studied:":[63],"(i)":[64],"daily":[65,178],"20":[67],"weeks":[68,88,95],"(sulindac-daily);":[69],"(ii)":[70],"2":[72,78],"weeks,":[73,79],"then":[74,90],"no":[75,91,100,161,223],"cycle":[80,195],"repeated":[81],"5":[82],"times":[83],"(sulindac-2);":[84],"(iii)":[85],"10":[87,94],"(\u201con\u201d),":[89],"(\u201coff\u201d;":[96],"sulindac-10);":[97],"(iv)":[99],"(sulindac-none).":[102],"Sulindac-2":[103],"sulindac-daily":[105],"had":[106,134],"statistically":[107,135],"significantly":[108,136],"lower":[109,137],"final":[110,138],"counts":[112],"slopes":[114,142],"(change":[115],"tumors":[119],"per":[120],"week)":[121],"when":[122,143],"compared":[123,144],"with":[124,145,160,196],"sulindac-none":[125,146],"(P":[126,147],"<":[127,148],"0.0001).":[128],"All":[129],"burdens":[140],"0.001).":[149],"There":[150],"a":[152,192,227,232],"prolonged":[153],"latency":[154],"period":[155,200],"sulindac-10":[158],"group,":[159],"significant":[162],"difference":[163],"between":[164],"\u201coff\u201d":[166],"portion":[167],"sulindac-none.":[172],"These":[173],"results":[174],"suggest":[175],"that,":[176],"although":[177],"doses":[179,188],"most":[184],"optimal":[185],"effects,":[186],"intermittent":[187],"50%":[193],"duty":[194],"overall":[198],"4-week":[199],"(sulindac-2":[201],"model)":[202],"highly":[205],"cancer":[210],"model.":[213],"After":[214],"cessation":[215],"(sulindac-10":[219],"\u201coff\u201d),":[220],"there":[221],"evidence":[224],"either":[226],"persistent":[228],"chemopreventive":[229],"effect":[230],"or":[231],"rebound":[233],"effect.":[234],"Cancer":[235],"Prev":[236],"Res;":[237],"10(8);":[238],"459\u201366.":[239],"\u00a92017":[240],"AACR.":[241]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-13T00:00:00"}